###begin article-title 0
###xml 28 33 <span type="species:ncbi:9606">human</span>
Physiogenomic comparison of human fat loss in response to diets restrictive of carbohydrate or fat
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Genetic factors that predict responses to diet may ultimately be used to individualize dietary recommendations. We used physiogenomics to explore associations among polymorphisms in candidate genes and changes in relative body fat (Delta%BF) to low fat and low carbohydrate diets.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
We assessed Delta%BF using dual energy X-ray absorptiometry (DXA) in 93 healthy adults who consumed a low carbohydrate diet (carbohydrate ~12% total energy) (LC diet) and in 70, a low fat diet (fat ~25% total energy) (LF diet). Fifty-three single nucleotide polymorphisms (SNPs) selected from 28 candidate genes involved in food intake, energy homeostasis, and adipocyte regulation were ranked according to probability of association with the change in %BF using multiple linear regression.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 280 284 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB</italic>
###xml 345 349 337 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL</italic>
###xml 405 409 397 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT</italic>
###xml 504 509 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2</italic>
Dieting reduced %BF by 3.0 +/- 2.6% (absolute units) for LC and 1.9 +/- 1.6% for LF (p < 0.01). SNPs in nine genes were significantly associated with Delta%BF, with four significant after correction for multiple statistical testing: rs322695 near the retinoic acid receptor beta (RARB) (p < 0.005), rs2838549 in the hepatic phosphofructokinase (PFKL), and rs3100722 in the histamine N-methyl transferase (HNMT) genes (both p < 0.041) due to LF; and the rs5950584 SNP in the angiotensin receptor Type II (AGTR2) gene due to LC (p < 0.021).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 80 85 80 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
###xml 89 94 89 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 136 142 136 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
Fat loss under LC and LF diet regimes appears to have distinct mechanisms, with PFKL and HNMT and RARB involved in fat restriction; and AGTR2 involved in carbohydrate restriction. These discoveries could provide clues to important physiologic mechanisms underlying the Delta%BF to low carbohydrate and low fat diets.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 142 143 142 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 214 215 214 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 562 563 562 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 688 689 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 756 757 756 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 855 857 855 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
Dietary modification remains a logical and fundamental approach to the treatment of obesity. Achieving success may depend on the diet chosen [1-4] and on innate and genetically inherited metabolic characteristics [5]. Ideally, a weight loss diet regimen should decrease excess adipose tissue mass, including the more important visceral fat, and preserve lean tissue. While weight loss occurs with any dietary strategy that restricts energy intake, it is clear that macronutrient composition has a role in determining adipose tissue and lean body mass responses [6]. In particular, changes in dietary carbohydrate affect substrate metabolism through responses of hormones such as insulin [7] that clearly induce macronutrient-dependent expression of genes [8,9]. Further, there are interindividual differences in metabolic processing of both carbohydrate [10] and fat [11,12] that have been implicated in obesity. In the present study, we compared the genetic variability associated with relative fat loss induced by energy restricted diets that varied in carbohydrate content. Such knowledge may ultimately lead to the development of DNA guided dietary recommendations.
###end p 11
###begin p 12
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 195 197 195 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The genes that influence the adipose tissue and lean body (skeletal muscle + bone) mass compartments alone or in response to dietary intervention remain uncharacterized [13,14]. Sorenson et al. [15] examined 42 SNPs in 26 candidate genes hypothesized to modulate obesity but found none to be predictive of the change in body mass index (BMI) induced by dietary restriction of either carbohydrate or fat. Although commonly used, BMI is not a precise surrogate index of adiposity. Its use as a phenotype may make genetic associations with a change in adiposity, difficult to discern.
###end p 12
###begin p 13
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 860 861 860 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 584 589 <span type="species:ncbi:9606">human</span>
In order to simultaneously assess relationships between many gene variants and the phenotype of relative body fat, the present study employed physiogenomics [16], a medical application of sensitivity analysis and systems engineering. Sensitivity analysis is the study of the relationship between input and output from a system as determined by system components. Physiogenomics utilizes the genes as the components of the system. The gene variability, measured by single nucleotide polymorphisms (SNPs), is correlated to physiological responses, the output, of a diversely responsive human population. Physiogenomics determines how the SNP frequency varies among individuals similarly responding to the input over the entire range of the response distribution. We have previously utilized physiogenomics to identify genes relevant to dietary weight reduction [5] and drug-induced side effects [17-19].
###end p 13
###begin p 14
###xml 187 191 187 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LIPF</italic>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS2</italic>
###xml 264 268 264 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CETP</italic>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL</italic>
###xml 295 296 295 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 511 513 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
The present study succeeds a previous physiogenomic study which found that the total body weight loss response to carbohydrate restriction was associated with variants in gastric lipase (LIPF), hepatic glycogen synthase (GYS2), cholesteryl ester transfer protein (CETP) and galanin (GAL) genes [5]. Here we extend that study to compare carbohydrate restriction to fat restriction, using the change in relative fat measured by dual energy X ray absorptiometry (DXA), an accurate method to assess percent fat [20,21], as a phenotype. We hypothesized that genes representative of food intake, energy homeostasis, and adipocyte regulation may explain the variability in the change in percent body fat accomplished through restriction of fat or carbohydrate.
###end p 14
###begin title 15
Methods
###end title 15
###begin title 16
Subjects and study design
###end title 16
###begin p 17
###xml 80 81 80 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 146 147 146 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 358 359 358 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 289 294 <span type="species:ncbi:9606">Human</span>
The subjects included 93 adults who participated in very low carbohydrate (LC) [1,22-25] and 70 who participated in low fat (LF) dietary studies [1,22] designed to examine the effects on weight loss, body composition, and other metabolic responses related to cardiovascular disease in the Human Performance Laboratory at the University of Connecticut (Table 1). The subjects were free of diabetes, cardiovascular, respiratory, gastrointestinal, thyroid and other metabolic disease. They were weight stable (+/- 2 kg) the month prior to starting the study. Subjects were not allowed to use nutritional supplements (except a daily multi-vitamin/mineral), or take medications to control blood lipids or glucose. The majority of subjects were sedentary and all were instructed to maintain the same level of physical activity throughout the study. The LC diet intervention was 12 weeks for the majority of subjects, but in some cases the duration was shorter (4-6 wk). Before and after LC and LF, body mass was determined in the morning after an overnight fast on a calibrated digital scale with subjects in light clothing and not wearing shoes. All subjects signed an informed consent document approved by the University of Connecticut Institutional Review Board.
###end p 17
###begin p 18
Demographic characteristics of the subjects in the low fat (LF) and low carbohydrate (LC) diet groups.
###end p 18
###begin title 19
Dietary protocols
###end title 19
###begin title 20
Low carbohydrate (LC)
###end title 20
###begin p 21
###xml 56 57 56 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 369 376 <span type="species:ncbi:9031">chicken</span>
###xml 378 384 <span type="species:ncbi:9103">turkey</span>
###xml 432 438 <span type="species:ncbi:3818">peanut</span>
The LC diet intervention has been described previously [5]. Subjects were free-living with the main goal to restrict carbohydrate (CHO) to a level that induced a small level of ketosis. There were no restrictions on the type of fat from saturated and unsaturated sources or cholesterol levels. Foods commonly consumed were beef (e.g., hamburger, steak), poultry (e.g., chicken, turkey), fish, vegetable oils, various nuts/seeds and peanut butter, moderate amounts of vegetables, salads with low CHO dressing, moderate amounts of cheese, eggs, protein drinks, and water or low CHO diet drinks. To ensure appropriate CHO restriction, subjects monitored their level of ketosis daily using urine reagent strips that produce a relative color change in the presence of one of the primary ketones, acetoacetic acid. Blood ketones were also checked during the diets. On this basis, all subjects were in ketosis for the majority of the experimental period. The actual mean nutrient breakdown of the diets as a percentage of total energy was obtained from at least 15 days of weighed food records across the various studies from which subjects were pooled.
###end p 21
###begin title 22
Low fat (LF)
###end title 22
###begin p 23
###xml 107 108 107 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
The LF diet was designed to provide <10% of total calories from saturated fat and <300 mg cholesterol/day [1]. Foods encouraged included whole grains (breads, cereals, and pastas), fruit and fruit juices, vegetables, vegetable oils, low-fat dairy and lean meat products. Standard diabetic exchange lists were used to foster a macronutrient balance of protein (~20% energy), fat (~25% energy), and carbohydrate (~55% of energy). All subjects received extensive initial verbal and written instructions and weekly follow-up dietetic education. Subjects received thorough instructions for completing detailed weighed food records during baseline and various phases of the diet that were subsequently analyzed using regularly updated nutrient analysis software (NUTRITIONIST PROtrade mark, Version 1.5, First Databank Inc, The Hearst Corporation, San Bruno, CA). The actual mean nutrient breakdown of the diets as a percentage of total energy was obtained from at least 15 days of weighed food records.
###end p 23
###begin title 24
Percent body fat measurement
###end title 24
###begin p 25
###xml 520 523 <span type="species:ncbi:9606">men</span>
###xml 528 533 <span type="species:ncbi:9606">women</span>
Whole body composition was assessed using DXA (Prodigytrade mark, Lunar Corporation, Madison, WI). Analyses were performed by the same technician (blinded as to dietary intervention) using commercial software (enCORE version 6.00.270). Percent body fat was calculated as soft tissue fat mass divided by the sum of soft tissue fat mass, soft tissue lean body mass, and bone mineral content. Coefficients of variation for lean body mass, fat mass, and bone mineral content on repeat scans with repositioning on a group of men and women in our laboratory were 0.4, 1.4, and 0.6%, respectively.
###end p 25
###begin title 26
Selection of candidate genes
###end title 26
###begin p 27
###xml 571 572 571 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
To identify genes involved in physiological responses to carbohydrate versus fat ingestion, we canvassed physiological pathways and biological processes relevant to the regulation of adiposity, including but not limited to eating behavior, digestion and absorption, hormonal signaling in the prandial and postprandial period, the regulation of fuel distribution and processing, and the control of adipocyte size and proliferation. From these categories, we selected 28 genes to represent three categories: food intake, energy homeostasis, and adipocyte regulation. Table 2 provides summary information relevant to the genes and SNPs. The role for each gene is described below.
###end p 27
###begin p 28
Genes and SNPs analyzed for associations with percent body fat change profiles for LF and LC groups.
###end p 28
###begin title 29
Food intake
###end title 29
###begin p 30
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL </italic>
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GHRL </italic>
###xml 55 57 55 57 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 159 164 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LIPF </italic>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PYY </italic>
###xml 541 543 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 546 550 546 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPY </italic>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 658 664 658 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NPY5R </italic>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 761 766 761 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEPR </italic>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 876 881 876 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MC3R </italic>
###xml 1065 1067 1065 1067 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1070 1076 1070 1076 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOA4 </italic>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1262 1264 1262 1264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
The GAL and GHRL genes, expressed in the hypothalamus [26] and stomach [27], respectively, encode for the orexigens galanin and ghrelin, respectively [26,27]. HNMT encodes for histamine N-methyl transferase, which inactivates histamine and is widely expressed in the stomach, thymus, lung, spleen, kidney, and particularly the brain [28]. LIPF encodes for gastric lipase, which hydrolyzes triglycerides, freeing fatty acids for intestinal uptake [29]. The PYY gene encodes for peptide YY, a gut endocrine factor that circulates after meals [30]. NPY encodes for neuropeptide Y, an abundant brain and autonomic neurotransmitter [31] and potent orexigen [32]. NPY5R encodes for one of five neuropeptide Y receptors studied in relation to energy balance [33]. The LEPR gene encodes for the leptin receptor, believed critical in the central regulation of energy homeostasis [34]. MC3R encodes for the melanocortin receptor 3, which regulates energy homeostasis in response to neuropeptides secreted by pro-opiomelanocortin and agouti related peptide releasing neurons [35]. APOA4 encodes for apolipoprotein A-IV, is expressed by intestinal cells in response to fat absorption [36], and has a hypothesized, centrally-mediated role in the regulation of energy intake [36].
###end p 30
###begin title 31
Energy homeostasis
###end title 31
###begin p 32
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GSK3B </italic>
###xml 109 111 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 133 136 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS</italic>
###xml 194 199 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS1 </italic>
###xml 203 208 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS2 </italic>
###xml 258 263 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
###xml 267 272 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKM </italic>
###xml 296 298 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 312 314 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 428 433 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PKLR </italic>
###xml 437 442 434 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PKM2 </italic>
###xml 544 546 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 553 557 550 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARA</italic>
###xml 559 563 556 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB</italic>
###xml 569 573 566 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARG</italic>
###xml 579 584 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RXRA </italic>
###xml 588 593 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RXRG </italic>
###xml 652 656 649 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAR </italic>
###xml 660 664 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RXR </italic>
###xml 745 747 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 821 823 818 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 824 826 821 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
GSK3B encodes for glycogen synthase kinase 3 beta-9, which inactivates glycogen synthase by phosphorylation [37]. Glycogen synthase (GYS) catalyzes the rate-limiting step in glycogen synthesis. GYS1 and GYS2 are expressed liver and muscle, respectively. The PFKL and PFKM genes encode the liver [38] and muscle [39] isoforms of phosphofructokinase, respectively. Phosphofructokinase is the key regulatory enzyme for glycolysis. PKLR and PKM2 encode for liver and muscle isoforms of pyruvate kinase, an enzyme of glycolysis and gluconeogenesis [37]. The RARA, RARB, and RARG; and RXRA and RXRG genes are members of the nuclear receptor superfamily. The RAR and RXR gene products participate in the regulation of energy balance at a neural level [40] and their expression in hepatic and adipose tissues is diet-responsive [41,42].
###end p 32
###begin title 33
Adipose regulation
###end title 33
###begin p 34
###xml 4 10 4 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACGT1 </italic>
###xml 14 20 14 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 140 148 140 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADIPOR2 </italic>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 331 336 331 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APOE </italic>
###xml 340 345 340 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CETP </italic>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 497 502 497 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RSTN </italic>
###xml 586 588 586 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
The ACGT1 and AGTR2 genes express angiotensin II receptors type I and II. Both play roles in adipocyte regulation and cellularity [43]. The ADIPOR2 gene encodes adiponectin receptor type I; muscle expression of this gene plays a role in non-oxidative glycolysis [44]. Apolipoprotein E and cholesteryl ester protein, encoded by the APOE and CETP genes, respectively, have widespread roles in lipid metabolism. Both are expressed in adipocytes [45-47] and subject to nutritional regulation [45,48]. RSTN encodes for the adipocyte-secreted factor, resistin, which is increased in obesity [49].
###end p 34
###begin title 35
Laboratory analysis
###end title 35
###begin p 36
###xml 518 520 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 521 523 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 632 633 614 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 219 231 <span type="species:ncbi:9606">participants</span>
Blood samples were collected from an arm vein into tubes for DNA extraction. The DNA was extracted from 8.5 mL of whole blood using the PreAnalytiX PAXgene DNA isolation kit (Qiagen Inc, Valencia, CA). For some earlier participants, neither whole blood nor DNA were available, so DNA from lymphocytes remaining in archived serum samples were amplified using the QiaGen REPLI-g Whole Genome Amplification kit. Genotyping was performed using the Illumina BeadArraytrade mark platform and the GoldenGatetrade mark assay [50,51]. The assay information and observed allele frequencies for the SNPs used in this study are listed in Table 3.
###end p 36
###begin p 37
Assay DNA sequences for the SNPs analyzed.
###end p 37
###begin p 38
Chr: chromosome location of the gene; mac: the number of minor alleles found; maj: sequence of the most common allele, major; min: sequence of the least common allele, minor; Freq: frequency (0.00-1.00) of the minor allele in the study population.
###end p 38
###begin title 39
Data analysis
###end title 39
###begin p 40
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1140 1142 1132 1134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1143 1145 1135 1137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
All statistical analysis was performed using the R Statistics Language and Environment [52-54]. Covariates were analyzed using multiple linear regression, and selected using the stepwise procedure. The change in relative fat mass, Delta%BF, was calculated as the difference between post-diet and baseline measurements of %BF. To test for association with SNP genotypes, the residual of Delta%BF after covariate analysis was tested using linear regression on the SNP genotypes. SNP genotype was coded quantitatively as a numerical variable indicating the number of minor alleles: 0 for major homozygotes, 1 for heterozygotes, and 2 for minor homozygotes. The F-statistic p-value for the SNP variable was used to evaluate the significance of association. To test the validity of the p-values, we also performed an independent calculation of the p-values using permutation testing. The ranking of the first three SNPs were identical under permutation and F-statistic analyses (data not shown). To account for the multiple testing of 53 SNPs, we calculated adjusted p-values using Benjamini and Hochberg's false discovery rate (FDR) procedure [55-57].
###end p 40
###begin title 41
LOESS representation
###end title 41
###begin p 42
###xml 251 253 247 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 254 256 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
We use a locally smoothed function of the SNP frequency as it varies with Delta%BF to visually represent the nature of an association. LOESS (LOcally wEighted Scatter plot Smooth) is a method to smooth data using a locally weighted linear regression [58,59]. At each point in the LOESS curve, a quadratic polynomial is fitted to the data in the vicinity of that point. The data are weighted such that they contribute less if they are further away, according to the tricubic function
###end p 42
###begin p 43

###end p 43
###begin p 44
###xml 6 8 6 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x </italic>
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 59 61 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i </italic>
###xml 59 61 59 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i </italic></sub>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">d</italic>
###xml 104 105 104 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 134 136 134 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x </italic>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">x</italic>
###xml 144 145 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 144 145 144 145 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>i</italic></sub>
where x is the abscissa of the point to be estimated, the xi are the data points in the vicinity, and d(x) is the maximum distance of x to the xi.
###end p 44
###begin title 45
Results
###end title 45
###begin title 46
Dietary intake
###end title 46
###begin p 47
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
The intake of total dietary energy at baseline did not differ between groups, nor did absolute amounts of protein, carbohydrate, and fat (Table 4). Relative to total energy intake, the intakes of protein, carbohydrate, and fat energy at baseline for LC and LF, expressed as percent of total energy, were 15.9%, 50.2%, and 32.6; and 16.6%, 47.7%, and 34.9%; respectively.
###end p 47
###begin p 48
Dietary data at baseline and during LF and LC interventions.
###end p 48
###begin p 49
###xml 0 7 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224; </sup>
dagger p < 0.01, LC vs. LF, within condition
###end p 49
###begin p 50
###xml 0 13 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#167; </sup>
###xml 19 22 8 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-10</sup>
section sign p < 1e-10, LC vs. LF, within condition
###end p 50
###begin p 51
* p < 0.05, Baseline vs. Diet, within group
###end p 51
###begin p 52
###xml 0 14 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8225; </sup>
double dagger p < 0.0001, Baseline vs. Diet, within group
###end p 52
###begin p 53
###xml 621 625 621 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e-10</sup>
###xml 633 634 633 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
Dietary intervention decreased mean total energy intake to 1470 kcal in LF and to 1705 kcal/day in LC (p < 0.01), representing mean changes from baseline of -32.5% and -26.5%, respectively. During intervention, carbohydrate intake averaged 212 g/day (57% of total energy) in LF compared to 53 g/day (12% of total energy intake) in LC. Protein intake averaged 94 g/day (19% of total energy) in LF and 115 g/day (28% of total energy) in LC. Fat intake averaged 37 g/day (23% of total energy) in LF and 112 g/day (59% of total energy) in LC. All between-group differences in macronutrient gram intake were significant (p < 1e-10, Table 4).
###end p 53
###begin title 54
Body mass and composition
###end title 54
###begin p 55
###xml 193 194 193 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
There were no differences in body size or composition between groups at baseline. With diet intervention, the change in total body, fat, and lean masses were significantly greater in LC (Table 5).
###end p 55
###begin p 56
Baseline and change in total body mass and composition for LC and LF.
###end p 56
###begin p 57
* p < 0.05, LC vs. LF
###end p 57
###begin p 58
###xml 0 14 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8225; </sup>
double dagger p < 0.0001, LC vs. LF
###end p 58
###begin p 59
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 680 681 672 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 772 773 760 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
###xml 540 543 <span type="species:ncbi:9606">Men</span>
###xml 556 561 <span type="species:ncbi:9606">women</span>
###xml 748 751 <span type="species:ncbi:9606">men</span>
###xml 759 764 <span type="species:ncbi:9606">women</span>
Figure 1 depicts the baseline and changes in % body fat profiles in the LF and LC study populations. The distributions are approximately normal and the baseline percent body fat levels for LF (35.4 +/- 7.8%) and LC (34.5% +/- 7.3%) were not different between groups. Overall LC induced an absolute decrease in % body fat of 2.98 +/- 2.62%, reflecting losses of 4.8 kg of fat mass and 1.42 kg of lean mass, compared to a % fat decrease of 1.92 +/- 1.63% in LF (p < 0.01), reflecting losses of 3.18 kg for fat mass and 0.70 kg for lean mass. Men outnumbered women in both study groups and had lower baseline % body fat in both groups (33.7 vs. 37.6 LF, and 32.9 vs. 38.0 LC) (Table 1). The change in % body fat (Delta%BF) due to diet was greater for men versus women (Table 5). For physiogenomics analyses, we employed gender as a covariate to account for the difference.
###end p 59
###begin p 60
###xml 112 121 112 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Frequency</italic>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
Distribution of baseline and change in percent body fat for LF (top) and LC (bottom) groups. The vertical axes (Frequency) indicates the number of patients observed within a given 10% interval up to 60% (baseline, left panels) or within a given 2% or 5% interval (change, right panels) on the horizontal axes. Genotyping was not completed in 3 LF subjects and 7 LC subjects.
###end p 60
###begin title 61
Physiogenomic associations
###end title 61
###begin p 62
###xml 6 7 6 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T6">6</xref>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 254 259 250 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 286 291 282 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
###xml 397 403 393 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 553 558 549 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 568 573 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 588 593 584 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
###xml 635 641 631 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
Table 6 lists the results of the association tests, comparing LF and LC groups. A single SNP rs322695 in the RARB gene was significantly associated with Delta%BF for both the LF and LC interventions (p < 0.0001 and p < 0.0121, respectively). SNPs in the HNMT (rs3100722, p < 0.002) and PFKL genes (rs2838549, p < 0.002) were significant only for the LF group. Conversely, the rs5950584 SNP in the AGTR2 gene was significant only for the LC group (p < 0.0001). The FDR-corrected p values yield an estimate of the false positive rate. The following SNPs, RARB rs322695, HNMT rs1269140, and PFKL rs2838549 and associations in LF, and the AGTR2 SNP rs5950584 association in LC are clearly significant after the FDR correction (p < 0.005, p < 0.041, p < 0.041, and p < 0.041, respectively). All remaining genes showed no significant association in either treatment group, and no gene showed significance for both diet treatments after adjusting for multiple tests.
###end p 62
###begin p 63
Significance levels of gene SNPs associated with % body fat change profiles for carbohydrate-restricted (LC) and fat-restricted (LF) diet treatments.
###end p 63
###begin p 64
Abbreviations: Coefficient: linear regression coefficient; FDR: false discovery rate p value, with those in bold type significant at alpha </= 0.05.
###end p 64
###begin p 65
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 523 528 519 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 585 590 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 604 609 600 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
###xml 634 639 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 653 658 649 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 677 682 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
Figure 2 shows the top three markers (according to p value) related to LF response. The first panel shows the LOESS curve for SNP rs322695 of the RARB gene. The frequency of the minor allele increases as the Delta%BF response to the LF diet becomes less pronounced (i.e., no loss of relative fat mass). The minor allele is completely absent among subjects with the largest decreases in %BF, and the frequency is <10% among subjects whose decrease in %BF exceeded 1%. This finding indicates a strong association between the RARB marker and response to LF. Similar patterns are seen for HNMT rs3100722 and PFKL SNP rs2838549. The SNPs, RARB SNP rs322695, HNMT SNP rs3100722, and PFKL SNP rs2838549, are considered "torpid" markers for responsiveness to the LF diet.
###end p 65
###begin p 66
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circles</italic>
###xml 204 213 200 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thin line</italic>
###xml 469 479 461 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thick line</italic>
###xml 567 577 555 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thick line</italic>
###xml 715 722 703 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circles</italic>
###xml 751 760 735 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thin line</italic>
###xml 118 125 <span type="species:ncbi:9606">patient</span>
###xml 241 248 <span type="species:ncbi:9606">patient</span>
Physiogenomic representation of the most significant genetic associations found in the low fat diet group. Individual patient genotypes (circles) of each SNP are overlaid on the distribution of Delta%BF (thin line). Each circle represents a patient, with the horizontal axis specifying the Delta%BF, and the vertical axis the carrier status for the minor allele: bottom, non-carriers; middle, single-carriers; top, double-carriers. A LOESS fit of the allele frequency (thick line) as a function of Delta%BF is shown. The ordinate is labeled for the marker frequency (thick line) of the SNP denoted at the top of each panel. The ordinate scale is the same in all three panels. The ordinate scales for the genotypes (circles) and Delta%BF distribution (thin line) are not shown. The abscissa is labeled for Delta%BF in each panel. The abscissa scale is the same in all three panels and applies identically to marker frequency, genotypes, and Delta%BF distribution.
###end p 66
###begin p 67
###xml 7 8 7 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 100 101 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 149 155 145 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 403 408 391 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS2 </italic>
###xml 497 502 485 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 636 641 620 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
Figure 3 shows the top three markers associated with Delta%BF through LC. The first panel in Figure 3 shows the LOESS curve for SNP rs5950584 of the AGTR2 gene. The frequency of the minor allele is 30% in the Delta%BF range that is less than -5%, and the minor allele is completely absent among subjects with subtle change in Delta%BF (i.e., no loss of relative fat). A similar pattern is seen with the GYS2 SNP rs1478290. These two SNPs are considered reactive markers. The third panel shows the RARB SNP rs322695 response. The minor allele shows a higher frequency in the subject with little response in Delta%BF, indicating that the RARB SNP rs322695 is a torpid marker of responsiveness to LC diet also.
###end p 67
###begin p 68
###xml 183 190 183 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">circles</italic>
###xml 223 232 219 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thin line</italic>
###xml 278 288 274 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">thick line</italic>
###xml 164 171 <span type="species:ncbi:9606">patient</span>
Physiogenomic representation of the most significant genetic associations found in the low carbohydrate group. See Figure 2 legend for details regarding individual patient genotypes (circles), the distribution of Delta%BF (thin line), and the LOESS fit of the allele frequency (thick line) as a function of Delta%BF.
###end p 68
###begin title 69
Discussion
###end title 69
###begin p 70
###xml 433 438 425 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 466 471 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 619 625 611 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 652 657 644 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
The present study shows that genetic associations with changes in Delta%BF established for genes in pathways encompassing food intake, energy homeostasis, and adipocyte regulation occur in part through common pathways, and in part through different pathways that may differentiate low fat (LF) and low carbohydrate (LC) restriction. For both diets, Delta%BF profiles assessed using DXA were affected by an intergenic SNP upstream of RARB (rs322695), suggesting that RARB is involved in a fat loss pathway common to both diets. In contrast, strong diet-specific associations were also found for a promoter region SNP in AGTR2 (rs5950584) through LC and PFKL through LF, suggesting that there are separate mechanisms for fat loss under the LF and LC diets.
###end p 70
###begin title 71
Physiogenomic associations common to both LF and LC
###end title 71
###begin p 72
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 99 104 99 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">both </italic>
###xml 388 390 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 397 402 393 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 470 474 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">THR </italic>
###xml 538 543 534 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 769 774 765 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 866 868 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 931 936 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 989 995 <span type="species:ncbi:9606">humans</span>
We observed a significant relationship between the RARB SNP rs322695 and change in relative fat to both diets after accounting for nongenetic factors. The relationship was significant after correction for multiple testing in mediation of the LF Delta%BF profiles (p < 0.005). This observation is noteworthy in light of the putative role of the retinoic acid system in insulin resistance [60]. The RARB SNP rs322695 is found 100 kb upstream and ~600 kb from the adjacent THR (thyroid hormone receptor) gene. We have attributed this SNP to RARB because it is the next gene downstream, and regulatory elements such as enhancers have been found several hundred kb from their transcription start sites. However, it cannot be excluded that the SNP effect may be unrelated to RARB protein expression, and rather involve an as yet uncharacterized protein or non-coding RNA [61]. We are unaware of other polymorphisms in the region or near RARB that are related to body weight or fat regulation in humans and believe this finding to be novel.
###end p 72
###begin p 73
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARE</italic>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 298 302 298 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RAR </italic>
###xml 404 409 404 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 547 552 547 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
The widespread genomic distribution of retinoic acid response elements (RARE) suggests participation in many physiological pathways [62-64]. Recently Morgan et al. [40] described a neural hypothesis for regulation of annual cycles of body fattening in animals in which changes in the expression of RAR in the arcuate nucleus of the brain were noted. Vitamin A deficiency preferentially decreases hepatic RARB expression [65], and regulates hepatic glucose metabolic enzymes [66]. Given that hepatic enzyme energy regulation occurs in part through RARB signaling, the present finding allows the hypothesis that the rs322695 variant affects such regulation.
###end p 73
###begin title 74
Physiogenomic associations specific to LF
###end title 74
###begin p 75
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 77 82 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
###xml 97 102 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 125 130 121 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 172 177 168 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
###xml 326 331 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 341 346 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 394 396 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 456 461 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HNMT </italic>
###xml 574 578 570 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL</italic>
###xml 620 622 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 655 657 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 678 683 674 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PFKL </italic>
###xml 737 739 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 388 392 <span type="species:ncbi:10090">mice</span>
In addition to the RARB gene, LF Delta%BF profiles had relationships through PFKL and one SNP in HNMT not found with LC. The HNMT SNP rs3100722, found at intron 2, and the PFKL SNP rs2838549, located in intron 8, showed significant relationships (p < 0.041) after correction for multiple tests) second in strength only to the RARB gene. The HNMT inhibitor metoprine suppresses feeding in mice [67]. The present finding enables us to hypothesize a role for HNMT in the regulation of food intake. Hepatic phosphofructokinase, a key regulatory enzyme for glycolysis encoded by PFKL, is responsive to macronutrient changes [68] and is regulated by Vitamin A [66]. Genetic loci near PFKL have been associated with bipolar affective disorder [69], but to our knowledge, no SNPs are known to modulate diet response.
###end p 75
###begin title 76
Physiogenomic associations specific to LC
###end title 76
###begin p 77
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2</italic>
###xml 231 237 231 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 343 349 343 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR1 </italic>
###xml 447 449 447 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 476 482 476 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 637 643 637 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 778 783 778 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2</italic>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 868 874 868 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 1016 1018 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 1116 1118 1116 1118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 452 458 <span type="species:ncbi:9606">Humans</span>
###xml 463 467 <span type="species:ncbi:10090">mice</span>
###xml 620 624 <span type="species:ncbi:10090">Mice</span>
The strongest association (p < 0.003, after correction for multiple tests) was found in the LC group with SNP rs5950584 in the angiotensin II receptor, type 2 (AGTR2). This SNP is found ~4.5 kb upstream in the promoter region. The AGTR2 gene has a metabolic role that is in contrast to the vascular role of the angiotensin II type 1 receptor (AGTR1 gene), which we previously found linked to statin-associated elevations in serum creatine kinase [17]. Humans and mice express AGTR2 in muscle and adipose tissue, and evidence supports the existence of a functional renin angiotensin II system within adipose tissue [70]. Mice lacking the AGTR2 receptor are resistant to the adipocyte hypertrophy and muscle cell insulin resistance induced by high fat, hypercaloric feeding [71]. AGTR2-dependent angiotensin II signaling thus could account for LC unresponsiveness [71]. AGTR2 polymorphisms were reported to modulate left ventricular mass, through the polymorphism known as G1675A (rs1403543) in a European population [72], and the T-A combination derived from G/T rs5193 and G/A rs5194 SNPs in a Cantonese population [73].
###end p 77
###begin p 78
###xml 26 32 26 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 133 136 <span type="species:ncbi:9606">men</span>
###xml 210 215 <span type="species:ncbi:9606">women</span>
###xml 268 271 <span type="species:ncbi:9606">Men</span>
###xml 305 310 <span type="species:ncbi:9606">women</span>
In the present study, the AGTR2 SNP rs5950584 serves as a reactive marker for the LC diet response. The AGTR2 gene is X-linked, thus men can have only one of either the T (major) or the G (minor) allele, while women may have zero, one, or two copies of either allele. Men lost significantly more fat than women, which together with the X-linked nature of the gene might lead to a false positive result. However, gender was highly significant in our covariate model, and the association test was performed adjusting for it, which excludes such a confounding effect.
###end p 78
###begin p 79
###xml 79 84 79 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS2 </italic>
###xml 94 99 94 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS2 </italic>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 213 218 213 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS2 </italic>
###xml 297 302 297 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS2 </italic>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 500 505 500 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GYS2 </italic>
Another association was found between LC response and the SNP rs1478290 in the GYS2 gene. The GYS2 product is glycogen synthase 2, a key regulator of hepatic glucose storage that is increased by feeding [74]. The GYS2 SNP rs1478290 is found in the promoter region. We previously found a different GYS2 SNP, rs2306179, located in intron 5, to be associated with body weight loss in response to LC diet [5]. The present study, conducted in a larger number of subjects, found also that a variant in the GYS2 gene is a response marker for the change in relative fat induced by LC.
###end p 79
###begin title 80
Differentiation of LF and LC diet responses
###end title 80
###begin p 81
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
The number of significant associations overall suggests a complex system through which regulation of the %BF phenotype is accomplished. Our list of genes, which is comparable to other studies to date [15], is exploratory, not comprehensive, and is representative of food intake, energy homeostasis, and adipocyte regulation. Virtually none of the genes in the present study were examined by previous diet studies [13,15]. Nevertheless, the present results showed a larger number of gene associations with Delta%BF profiles in relation to the LF diet compared to the LC diet. Based simply on the numbers of genes found to be significantly associated, we infer that the low fat diet utilizes a greater number of signal inputs into the regulation of relative body fat compared to the low carbohydrate diet. Even after the most stringent correction for multiple testing, RARB remained significantly associated with LF Delta%BF and AGTR2 remained associated with LC Delta%BF.
###end p 81
###begin p 82
###xml 53 55 53 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 519 521 511 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 607 613 599 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">per se</italic>
###xml 846 848 838 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vs</italic>
###xml 910 912 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Our findings run counter to those of a recent study [15] that reported no significant SNP associations with changes in BMI following carbohydrate or fat restriction despite using large cohorts. Methodological differences between the studies are worth noting. The present study used DXA to precisely assess Delta%BF as opposed to relying on BMI. Second, different genes were studied. Here, the selection of genes was designed to reflect Delta%BF phenotype variability. In contrast, the SNPs examined by Sorenson et al. [15] were those demonstrated in previous reports to affect obesity and not diet response per se. Macronutrient compositions of the intervention diets were quite dichotomous in the present study, especially for carbohydrate (~12% and 57% of total energy as carbohydrate in the LC and LF arms, respectively, in the present study; vs. 42% and 57%, respectively, in the study of Sorenson et al. [15]). We believe a greater imbalance in the macronutrient combination increases the strength of the dietary stimuli, which accentuates differences in the physiological signal intensities associated with each diet, increasing the chances for detection of physiogenomic relationships.
###end p 82
###begin title 83
Clinical implication
###end title 83
###begin p 84
###xml 466 467 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 369 376 <span type="species:ncbi:9606">patient</span>
###xml 575 583 <span type="species:ncbi:9606">patients</span>
###xml 945 952 <span type="species:ncbi:9606">patient</span>
The prevention and treatment of obesity could be more efficient if dietary recommendations were carried out based on knowledge of innate individual characteristics that are genetically predictable. Moreover, adherence to dietary advice may increase when the advice is personalized. DNA-guided regimens allow healthcare providers to tailor therapies based on individual patient characteristics, rather than the average diet responses applied in longitudinal studies [3,75]. A dietary treatment with a higher average chance for success, for example, may be desirable for those patients who inherited an ensemble of DNA markers with the most responsive factors and the least torpid factors for it. We interpret the coefficients associated with each significant gene marker in Table 4 as either having responsive or torpid effects to facilitate fat loss. The ability to match a diet regimen's genetic "contour" with the DNA profile of an individual patient marks the beginning of high-resolution personalized nutritional medicine for the treatment and prevention of obesity.
###end p 84
###begin title 85
Limitations
###end title 85
###begin p 86
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RARB </italic>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AGTR2 </italic>
###xml 1020 1023 <span type="species:ncbi:9606">men</span>
###xml 1028 1033 <span type="species:ncbi:9606">women</span>
The number of subjects studied, the list of genes analyzed, and in some cases the frequency of the minor allele in SNPs of interest, were relatively small. Thus the results will need to be validated before clinical application. Nevertheless, the RARB and AGTR2 results are clearly significant even when fully and most conservatively corrected for multiple comparisons. The p-values were confirmed by non-parametric permutation analysis, excluding non-normal distribution as a source of false positives. In addition, the RARB result was found in the LF group and independently confirmed in the LC group. Although we assessed only a small sample of SNPs in the genome, this study included 53 SNPs from 28 genes representing a larger ensemble of genetic probes than other published diet studies. The data for the present study were compiled from a series of studies in whom the majority of subjects were of European ancestry. We lack power to detect ethnogeographic associations or confounding effects. We did not consider men and women separately but accounted for the effect of gender through its use as a covariate. Future studies investigating a sex difference might be useful. Finally, both diets were hypocaloric. It is possible that the genes shown to exert their effects through both diets, actually do so through the commonality of caloric restriction.
###end p 86
###begin title 87
Authors' contributions
###end title 87
###begin p 88
RLS drafted the manuscript. JSV conceived of the study, designed and executed many of the diet restriction studies that supplied DNA, and helped draft the manuscript. AW participated in the design of the study, oversaw the genetic analyses, and performed the statistical analysis. MK performed the molecular genetic analyses. MLF participated in the design of the study and conducted some of the diet restriction studies that supplied DNA samples. WK participated in the design and coordination of diet restriction studies that supplied DNA and phenotype information. GR participated in the study design, provided oversight for genetic analyses and helped to draft the manuscript. All authors read and approved the final manuscript.
###end p 88
###begin title 89
Acknowledgements
###end title 89
###begin p 90
This research was funded by grants from the University of Connecticut Center for Science & Technology Commercialization and by Genomas internal research and development funds.
###end p 90
###begin article-title 91
###xml 122 125 <span type="species:ncbi:9606">men</span>
###xml 130 135 <span type="species:ncbi:9606">women</span>
Comparison of energy-restricted very low-carbohydrate and low-fat diets on weight loss and body composition in overweight men and women
###end article-title 91
###begin article-title 92
Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia
###end article-title 92
###begin article-title 93
###xml 133 138 <span type="species:ncbi:9606">women</span>
Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial
###end article-title 93
###begin article-title 94
A randomized trial of a low-carbohydrate diet for obesity
###end article-title 94
###begin article-title 95
Physiogenomic analysis of weight loss induced by dietary carbohydrate restriction
###end article-title 95
###begin article-title 96
Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression 1
###end article-title 96
###begin article-title 97
Effects of dietary carbohydrate restriction with high protein intake on protein metabolism and the somatotropic axis
###end article-title 97
###begin article-title 98
###xml 64 68 <span type="species:ncbi:10090">Mice</span>
A High Fat, Ketogenic Diet, Induces a Unique Metabolic State in Mice
###end article-title 98
###begin article-title 99
###xml 117 124 <span type="species:ncbi:9606">persons</span>
Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study
###end article-title 99
###begin article-title 100
Carbohydrate balance predicts weight and fat gain in adults
###end article-title 100
###begin article-title 101
Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ
###end article-title 101
###begin article-title 102
###xml 109 115 <span type="species:ncbi:9606">humans</span>
Nutrient balance and energy expenditure during ad libitum feeding of high-fat and high-carbohydrate diets in humans
###end article-title 102
###begin article-title 103
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human obesity gene map: the 2005 update
###end article-title 103
###begin article-title 104
Does weight loss prognosis depend on genetic make-up?
###end article-title 104
###begin article-title 105
Genetic Polymorphisms and Weight Loss in Obesity: A Randomised Trial of Hypo-Energetic High- versus Low-Fat Diets
###end article-title 105
###begin article-title 106
Physiogenomics: Integrating Systems Engineering and Nanotechnology for Personalized Medicine
###end article-title 106
###begin article-title 107
Physiogenomic analysis links serum creatine kinase activities during statin therapy to vascular smooth muscle homeostasis
###end article-title 107
###begin article-title 108
###xml 83 91 <span type="species:ncbi:9606">patients</span>
Physiogenomic comparison of weight profiles of olanzapine- and risperidone-treated patients
###end article-title 108
###begin article-title 109
Physiogenomic Association of Statin-Related Myalgia to Serotonin Receptors
###end article-title 109
###begin article-title 110
Dual energy X-ray absorptiometry assessment of fat mass distribution and its association with the insulin resistance syndrome
###end article-title 110
###begin article-title 111
Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity
###end article-title 111
###begin article-title 112
###xml 254 259 <span type="species:ncbi:9606">women</span>
An isoenergetic very low carbohydrate diet improves serum HDL cholesterol and triacylglycerol concentrations, the total cholesterol to HDL cholesterol ratio and postprandial pipemic responses compared with a low fat diet in normal weight, normolipidemic women
###end article-title 112
###begin article-title 113
Body composition and hormonal responses to a carbohydrate-restricted diet
###end article-title 113
###begin article-title 114
###xml 96 99 <span type="species:ncbi:9606">men</span>
A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men
###end article-title 114
###begin article-title 115
###xml 135 138 <span type="species:ncbi:9606">men</span>
Carbohydrate restriction alters lipoprotein metabolism by modifying VLDL, LDL, and HDL subfraction distribution and size in overweight men
###end article-title 115
###begin article-title 116
Overconsumption of dietary fat and alcohol: Mechanisms involving lipids and hypothalamic peptides
###end article-title 116
###begin article-title 117
###xml 111 115 <span type="species:ncbi:10090">mice</span>
Ghrelin-induced food intake and growth hormone secretion are altered in melanocortin 3 and 4 receptor knockout mice
###end article-title 117
###begin article-title 118
HNMT, histamine N-methyl transferase, function
###end article-title 118
###begin article-title 119
LIPF, Gastic Lipase, function
###end article-title 119
###begin article-title 120
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human distribution and release of a putative new gut hormone, peptide YY
###end article-title 120
###begin article-title 121
Molecular characterization of the ligand-receptor interaction of neuropeptide Y
###end article-title 121
###begin article-title 122
Treating obesity: does antagonism of NPY fit the bill?
###end article-title 122
###begin article-title 123
Effect of NPY5R antagonist MK-0557 on weight regain after very-low-calorie diet-induced weight loss
###end article-title 123
###begin article-title 124
Genetic dissection of neuronal pathways controlling energy homeostasis
###end article-title 124
###begin article-title 125
The melanocortin system and energy balance
###end article-title 125
###begin article-title 126
Apolipoprotein A-IV, food intake, and obesity
###end article-title 126
###begin article-title 127
PFKL, phosphofructokinase, liver, function
###end article-title 127
###begin article-title 128
PFKM, phosphofructokinase, muscle, function
###end article-title 128
###begin article-title 129
What can we learn from seasonal animals about the regulation of energy balance?
###end article-title 129
###begin article-title 130
###xml 166 169 <span type="species:ncbi:10116">rat</span>
Exposure to an obesity-inducing diet early affects the pattern of expression of peroxisome proliferator, retinoic acid, and triiodothyronine nuclear receptors in the rat
###end article-title 130
###begin article-title 131
###xml 125 129 <span type="species:ncbi:10116">rats</span>
Dietary soy protein isolate modifies hepatic retinoic acid receptor-beta proteins and inhibits their DNA binding activity in rats
###end article-title 131
###begin article-title 132
The role of angiotensin II and its receptors in regulation of adipose tissue metabolism and cellularity
###end article-title 132
###begin article-title 133
Relationships of plasma adiponectin level and adiponectin receptors 1 and 2 gene expression to insulin sensitivity and glucose and fat metabolism in monozygotic and dizygotic twins
###end article-title 133
###begin article-title 134
Nutritional regulation of adipose tissue apolipoprotein E expression
###end article-title 134
###begin article-title 135
Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA
###end article-title 135
###begin article-title 136
###xml 26 31 <span type="species:ncbi:9606">human</span>
Cloning and sequencing of human cholesteryl ester transfer protein cDNA
###end article-title 136
###begin article-title 137
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 61 76 <span type="species:ncbi:10090">transgenic mice</span>
Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element
###end article-title 137
###begin article-title 138
Insulin resistance and obesity: resistin, a hormone secreted by adipose tissue
###end article-title 138
###begin article-title 139
Highly parallel SNP genotyping
###end article-title 139
###begin article-title 140
BeadArray technology: enabling an accurate, cost-effective approach to high-throughput genotyping
###end article-title 140
###begin article-title 141
Identifying differentially expressed genes using false discovery rate controlling procedures
###end article-title 141
###begin article-title 142
Controlling the false discovery rate: a practical and powerful approach to multiple testing
###end article-title 142
###begin article-title 143
On the adaptive control of the false discovery rate in multiple testing with independent statistics
###end article-title 143
###begin article-title 144
Locally weighted regression: an approach to regression analysis by local fitting
###end article-title 144
###begin article-title 145
Robust locally weighted regression and smoothing scatterplots
###end article-title 145
###begin article-title 146
Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes
###end article-title 146
###begin article-title 147
The functional genomics of noncoding RNA
###end article-title 147
###begin article-title 148
Retinoids and Hox genes
###end article-title 148
###begin article-title 149
Cytochrome P450RAI(CYP26) promoter: a distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism
###end article-title 149
###begin article-title 150
Retinoid regulation of the phosphoenolpyruvate carboxykinase gene in liver
###end article-title 150
###begin article-title 151
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Vitamin A regulates genes involved in hepatic gluconeogenesis in mice: phosphoenolpyruvate carboxykinase, fructose-1,6-bisphosphatase and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase
###end article-title 151
###begin article-title 152
###xml 144 148 <span type="species:ncbi:10116">rats</span>
Metoprine, an inhibitor of histamine N-methyltransferase but not catechol-O-methyltransferase, suppresses feeding in sated and in food deprived rats
###end article-title 152
###begin article-title 153
Time course of enzyme changes after a switch from a high-fat to a low-fat diet
###end article-title 153
###begin article-title 154
A follow-up linkage study supports evidence for a bipolar affective disorder locus on chromosome 21q22
###end article-title 154
###begin article-title 155
###xml 51 56 <span type="species:ncbi:9606">human</span>
Co-expression of renin-angiotensin system genes in human adipose tissue
###end article-title 155
###begin article-title 156
Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance
###end article-title 156
###begin article-title 157
Left ventricular mass in relation to genetic variation in angiotensin II receptors, renin system genes, and sodium excretion
###end article-title 157
###begin article-title 158
Angiotensin II type 2 receptor gene polymorphisms and cardioprotective role in essential hypertension
###end article-title 158
###begin article-title 159
###xml 99 103 <span type="species:ncbi:10116">rats</span>
Effect of feeding, fasting, and diabetes on liver glycogen synthase activity, protein, and mRNA in rats
###end article-title 159
###begin article-title 160
Quo Vadis Personalized Medicine?
###end article-title 160

